{
  "id": "5a9700adfcd1d6a10c00002c",
  "type": "factoid",
  "question": "Sclerostin regulates what process?",
  "ideal_answer": "Sclerostin plays a critical role in bone homeostasis and its deficiency or pharmacological neutralization increases bone formation",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/20043874",
    "http://www.ncbi.nlm.nih.gov/pubmed/23233270",
    "http://www.ncbi.nlm.nih.gov/pubmed/27342581",
    "http://www.ncbi.nlm.nih.gov/pubmed/25248363",
    "http://www.ncbi.nlm.nih.gov/pubmed/22836717",
    "http://www.ncbi.nlm.nih.gov/pubmed/28571484",
    "http://www.ncbi.nlm.nih.gov/pubmed/26826396",
    "http://www.ncbi.nlm.nih.gov/pubmed/24151757",
    "http://www.ncbi.nlm.nih.gov/pubmed/22206666",
    "http://www.ncbi.nlm.nih.gov/pubmed/27742498",
    "http://www.ncbi.nlm.nih.gov/pubmed/27965160",
    "http://www.ncbi.nlm.nih.gov/pubmed/24949665",
    "http://www.ncbi.nlm.nih.gov/pubmed/23737439",
    "http://www.ncbi.nlm.nih.gov/pubmed/23845326",
    "http://www.ncbi.nlm.nih.gov/pubmed/21312267",
    "http://www.ncbi.nlm.nih.gov/pubmed/21991382",
    "http://www.ncbi.nlm.nih.gov/pubmed/28081119",
    "http://www.ncbi.nlm.nih.gov/pubmed/22082361",
    "http://www.ncbi.nlm.nih.gov/pubmed/21890009",
    "http://www.ncbi.nlm.nih.gov/pubmed/12702725"
  ],
  "snippets": [
    {
      "text": " Sclerostin is a soluble antagonist of Wnt/\u03b2-catenin signaling secreted primarily by osteocytes. Current evidence indicates that sclerostin likely functions as a local/paracrine regulator of bone metabolism rather than as an endocrine hormone. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27965160",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "After discovering that lack of Sost/sclerostin expression is the cause of the high bone mass human syndromes Van Buchem disease and sclerosteosis, extensive animal experimentation and clinical studies demonstrated that sclerostin plays a critical role in bone homeostasis and that its deficiency or pharmacological neutralization increases bone formation",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27742498",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21312267",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The osteocyte product sclerostin is emerging as an important paracrine regulator of bone mass.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23737439",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sclerostin is a secreted inhibitor of Wnt signaling and plays an essential role in the regulation of bone mass.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21890009",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sclerostin secreted by osteocytes is mechanosensory and important in bone remodeling.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28081119",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sclerostin negatively regulates Wnt signaling pathway and also has an important role in postmenopausal bone loss.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26826396",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sclerostin regulates bone formation by inhibiting Wnt pathway signaling.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22836717",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sclerostin, an osteocyte-expressed negative regulator of bone formation, is one of the inhibitors of Wnt signaling that is a critical pathway in the correct process of osteoblast differentiation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22082361",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sclerostin, a secreted glycoprotein, regulates osteoblast function.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20043874",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sclerostin regulates bone formation by inhibiting Wnt/\u03b2-catenin signaling.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23845326",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We suggest that sclerostin negatively regulates the formation of bone by repressing the differentiation and/or function of osteoblasts induced by BMPs.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12702725",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sclerostin negatively regulates Wnt signaling pathway and also has an important role in postmenopausal bone loss.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26826396",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Since sclerostin expression is confined to the bone-resorbing osteoclast, it provides a mechanism whereby bone apposition is inhibited in the vicinity of resorption.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12702725",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sclerostin regulates bone formation by inhibiting Wnt/\u03b2-catenin signaling.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23845326",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23737439",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The secreted glycoprotein, sclerostin alters bone formation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22206666",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sclerostin, encoded by the sost gene, and a product of the osteocyte, is a negative regulator of bone formation. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24949665",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sclerostin is a Wnt pathway antagonist regulating osteoblast activity and bone turnover, and it plays a role in cardiovascular calcification processes. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25248363",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Sclerostin plays a major role in regulating skeletal bone mass, but its effects in articular cartilage are not known.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23233270",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sclerostin is a key negative regulator of bone formation",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24151757",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sclerostin is a product of mature osteocytes embedded in mineralised bone and is a negative regulator of bone mass and osteoblast differentiation",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21991382",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In humans, the SOST gene encodes sclerostin, an inhibitor of bone growth and remodeling, which also negatively regulates the bone repair process.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28571484",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The glycoprotein sclerostin (Scl; 22 kDa), which is involved in bone metabolism, ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27342581",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.uniprot.org/uniprot/SOST_CHLAE",
    "http://www.uniprot.org/uniprot/SOST_BOVIN",
    "http://www.uniprot.org/uniprot/SOST_MOUSE"
  ],
  "exact_answer": "bone metabolism"
}